180 Life Sciences Corp(ATNF),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ATNF 180 Life Sciences Corp

Post-Mkt 04-15 19:11:40 EDT

0.8900

+0.0380

+4.46%

盘后0.8901

+0.0001+0.01%

18:19 EDT

High0.9365	Low0.8611	Vol41.18K
Open0.8700	D1 Closing0.8520	Amplitude8.85%
Mkt Cap4.62M	Tradable Cap3.79M	Total Shares5.19M
T/O37.20K	T/O Rate0.97%	Tradable Shares4.26M
P/B0.50	ROE-135.21%	EPS-3.95
52wk High17.75	52wk Low0.6578	P/E-0.23
Dividend0.00	Div.Yield0.00	ROA-43.87%

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"ATNF","market":"US","secType":"STK","nameCN":"180 Life Sciences Corp","latestPrice":0.89,"timestamp":1744747200000,"preClose":0.852,"halted":0,"volume":41178,"hourTrading":{"tag":"盘后","latestPrice":0.8901,"preClose":0.89,"latestTime":"18:19 EDT","volume":788,"amount":702.1912916,"timestamp":1744755577240},"delay":0,"floatShares":4259200,"shares":5185780,"eps":-3.951863,"marketStatus":"Post-Mkt","change":0.038,"latestTime":"04-15 19:11:37 EDT","open":0.87,"high":0.936501,"low":0.8611,"amount":37201.3870086,"amplitude":0.088499,"askPrice":1,"askSize":100,"bidPrice":0.7408,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.951863,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1744761600000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":0.852,"preHourTrading":{"tag":"盘前","latestPrice":0.81,"preClose":0.852,"latestTime":"08:56 EDT","volume":325,"amount":263.25,"timestamp":1744721769968},"postHourTrading":{"tag":"盘后","latestPrice":0.8901,"preClose":0.89,"latestTime":"18:19 EDT","volume":788,"amount":702.1912916,"timestamp":1744755577240},"volumeRatio":0.097608,"impliedVol":1.2989,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/ATNF","defaultTab":"news","newsList":[{"id":"2514040479","title":"Blair Jordan Reports 10.5% Stake in 180 Life Sciences Corp as of Feb 20 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2514040479","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514040479?lang=en_us&edition=full_marsco","pubTime":"2025-02-26 06:38","pubTimestamp":1740523085,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nFWN3PG0YP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ATNF","BK4139"],"gpt_icon":0},{"id":"2494336890","title":"Top Midday Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2494336890","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494336890?lang=en_us&edition=full_marsco","pubTime":"2024-12-28 02:10","pubTimestamp":1735323001,"startTime":"0","endTime":"0","summary":"180 Life Sciences (ATNF) priced a $2.9 million at-the-market direct offering of stock and warrants and a concurrent private placement, the biotechnology company said on Friday. 180 Life Science issued","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","KEY","BK4135","ATNF","KEY.AU","BK4589","BK4211","BK7142","BK4585","BK4207","BK4139","BNS","BAM"],"gpt_icon":0},{"id":"2494386686","title":"180 Life Sciences Launches $2.9 Million Registered Direct Offering, Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2494386686","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494386686?lang=en_us&edition=full_marsco","pubTime":"2024-12-27 22:43","pubTimestamp":1735310618,"startTime":"0","endTime":"0","summary":"180 Life Sciences  said Friday it agreed to sell 1.2 million shares in a registered direct offering and warrants to buy up to 1.2 million shares in a private placement at a combined price of $2.41 per share and accompanying warrant to several investors.Gross proceeds from the offering are expected at around $2.9 million, 180 Life Sciences said.The company said the warrants are exercisable immediately at an exercise price of $2.28 per share and will expire 5.5 years after the date of issuance.180 Life Sciences expects to close the offering around Monday.Shares of the company fell more than 10% in early trading Friday.Price: 2.53, Change: -0.30, Percent Change: -10.60","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","ATNF"],"gpt_icon":0},{"id":"2494085383","title":"180 Life Sciences prices $2.9M registered direct offering at $2.41 per share","url":"https://stock-news.laohu8.com/highlight/detail?id=2494085383","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494085383?lang=en_us&edition=full_marsco","pubTime":"2024-12-27 22:10","pubTimestamp":1735308608,"startTime":"0","endTime":"0","summary":"180 Life Sciences (ATNF) announced that it has entered into a securities purchase agreement with several institutional investors to sell 1,200,000 ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/180-life-sciences-prices-2-9m-registered-direct-offering-at-2-41-per-share?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/180-life-sciences-prices-2-9m-registered-direct-offering-at-2-41-per-share?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ATNF"],"gpt_icon":0},{"id":"2494383665","title":"180 Life Sciences Corp: Announces Pricing of $2.9 Mln Registered Direct Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2494383665","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494383665?lang=en_us&edition=full_marsco","pubTime":"2024-12-27 22:04","pubTimestamp":1735308290,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241227:nFWN3NR05F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ATNF"],"gpt_icon":0},{"id":"2494385844","title":"180 Life Sciences Corp. Announces Pricing of $2.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under NASDAQ Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2494385844","media":"ACCESSWIRE","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494385844?lang=en_us&edition=full_marsco","pubTime":"2024-12-27 22:00","pubTimestamp":1735308000,"startTime":"0","endTime":"0","summary":"PALO ALTO, CALIFORNIA / ACCESSWIRE / December 27, 2024 / 180 Life Sciences Corp.  , a biotechnology company that is currently refocusing its business on the international entertainment and iGaming sector, today announced that it has entered into a securities purchase agreement with several institutional investors to sell 1,200,000 shares of common stock in a registered direct offering priced at market under Nasdaq rules. In a concurrent private placement, the Company also agreed to issue unregistered warrants to purchase up to an aggregate of 1,200,000 shares of common stock. The combined effective offering price for each share of common stock and accompanying warrants is $2.41. The warrants will have an exercise price of $2.28 per share, will be exercisable immediately, and expire on the five and a half year anniversary from the date of issuance.180 Life Sciences Corp. is an innovative biotechnology company that is focused on advancing breakthrough treatments. W","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/180-life-sciences-corp-announces-140000510.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NQmain","USJW.SI","PSQ","IE00B3QW5Z07.USD","NVIW.SI","IE00B64PRP62.GBP","SQQQ","IE00BGHQF748.EUR","QLD","BK4139",".IXIC","NDAQ","MNQmain","BK4215","USAW.SI","TQQQ","TSYW.SI","MAA","BK4585","BK4112","IE00BKPKM429.USD","LU2095319765.USD","ATNFW","ATNF","QID","BK4588","LU2210149790.SGD","LU2210150020.SGD"],"gpt_icon":1},{"id":"2492157594","title":"BRIEF-180 Life Sciences Corp - On Dec 16, Omar Jimenez Resigns As CFO Of 180 Life Sciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2492157594","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492157594?lang=en_us&edition=full_marsco","pubTime":"2024-12-19 05:48","pubTimestamp":1734558527,"startTime":"0","endTime":"0","summary":"BRIEF-180 Life Sciences Corp - On Dec 16, Omar Jimenez Resigns As CFO Of 180 Life SciencesDec 18  - 180 Life Sciences Corp ATNF.O:180 LIFE SCIENCES CORP - ON DEC 16, OMAR JIMENEZ RESIGNS AS CFO OF 180 LIFE SCIENCES180 LIFE SCIENCES CORP - BLAIR JORDAN ASSUMES CFO ROLE ON INTERIM BASISSource text: [ID:n0001213900-24-110152]Further company coverage: ATNF.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241218:nFWN3NJ0T9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATNF","BK4139"],"gpt_icon":0},{"id":"2492215421","title":"180 Life Sciences Corp - on Dec 16, Omar Jimenez Resigns as CFO of 180 Life Sciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2492215421","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492215421?lang=en_us&edition=full_marsco","pubTime":"2024-12-19 05:17","pubTimestamp":1734556630,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241218:nFWN3NJ0T9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ATNF","BK4139"],"gpt_icon":0},{"id":"2490884033","title":"180 Life Sciences Corp: Regains Full Compliance With Nasdaq Listing Rule 5605(C)(2)","url":"https://stock-news.laohu8.com/highlight/detail?id=2490884033","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490884033?lang=en_us&edition=full_marsco","pubTime":"2024-12-12 21:04","pubTimestamp":1734008679,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241212:nFWN3ND10Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ATNF","BK4139"],"gpt_icon":0},{"id":"2490038340","title":"180 Life Sciences Corp. Regains Full Compliance with Nasdaq Continued Listing Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2490038340","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490038340?lang=en_us&edition=full_marsco","pubTime":"2024-12-12 21:00","pubTimestamp":1734008400,"startTime":"0","endTime":"0","summary":"PALO ALTO, CA / ACCESSWIRE / December 12, 2024 / 180 Life Sciences Corp.  is pleased to announce that it has regained compliance with Nasdaq Listing Rule 5605, which requires Nasdaq listed companies to maintain an audit committee consisting of three independent directors. This development follows the recent appointment of Mr. Stephen Shoemaker as an independent director of the Company and as a member of the Company's audit committee. With this appointment, 180 is now in full compliance with all Nasdaq continued listing requirements and has remedied all previously announced deficiencies.Mr. Blair Jordan, Interim CEO of the Company, stated, \"This brings 180 into full compliance with Nasdaq's continued listing rules, eliminating any uncertainty around Nasdaq compliance issues. The entire management team is now firmly focused on executing on our previously announced pivot into the iGaming sector.\". Mr. Jordan further emphasized, \"We continue to believe that the Technology Gaming Platform t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/180-life-sciences-corp-regains-130000219.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ATNF","BK4585","BK4139","LU2095319765.USD","MAA",".IXIC","IE00BKPKM429.USD","IE00BGHQF748.EUR","LU2210149790.SGD","LU2210150020.SGD","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","BK4588","ATNFW","BK4215","BK4112","NDAQ"],"gpt_icon":0},{"id":"2483225534","title":"BRIEF-180 Life Sciences Corp Files For Offering Of Up To 1.9 Million Shares By The Selling Stockholder - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2483225534","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483225534?lang=en_us&edition=full_marsco","pubTime":"2024-11-16 07:02","pubTimestamp":1731711733,"startTime":"0","endTime":"0","summary":"BRIEF-180 Life Sciences Corp Files For Offering Of Up To 1.9 Million Shares By The Selling Stockholder - SEC FilingNov 15  - 180 Life Sciences Corp ATNF.O:180 LIFE SCIENCES CORP FILES FOR OFFERING OF UP TO 1.9 MILLION SHARES BY THE SELLING STOCKHOLDER - SEC FILINGSource text: [ID:n0001213900-24-099114]Further company coverage: ATNF.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241115:nFWN3MM18V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATNF","BK4139"],"gpt_icon":0},{"id":"2483533506","title":"180 Life Sciences files to sell 1.9M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2483533506","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483533506?lang=en_us&edition=full_marsco","pubTime":"2024-11-16 05:20","pubTimestamp":1731705634,"startTime":"0","endTime":"0","summary":"16:17 EST 180 Life Sciences (ATNF) files to sell 1.9M shares of common stock for holders Published first on TheFly – the ultimate source for real-t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/180-life-sciences-files-to-sell-1-9m-shares-of-common-stock-for-holders?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/180-life-sciences-files-to-sell-1-9m-shares-of-common-stock-for-holders?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ATNF"],"gpt_icon":0},{"id":"2479483086","title":"180 Life Sciences appoints Vaclav Vincalek as Senior Technology Consultant","url":"https://stock-news.laohu8.com/highlight/detail?id=2479483086","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479483086?lang=en_us&edition=full_marsco","pubTime":"2024-10-31 20:32","pubTimestamp":1730377930,"startTime":"0","endTime":"0","summary":"180 Life Sciences (ATNF) announced the retention of Vaclav Vincalek as Senior Technology Consultant. Vincalek will work closely with management to ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/180-life-sciences-appoints-vaclav-vincalek-as-senior-technology-consultant?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/180-life-sciences-appoints-vaclav-vincalek-as-senior-technology-consultant?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ATNF","BK4139"],"gpt_icon":0},{"id":"2479085145","title":"180 Life Sciences Corp. Retains Senior Technology Consultant and Commences Gaming Technology Platform Integration","url":"https://stock-news.laohu8.com/highlight/detail?id=2479085145","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479085145?lang=en_us&edition=full_marsco","pubTime":"2024-10-31 20:00","pubTimestamp":1730376000,"startTime":"0","endTime":"0","summary":"PALO ALTO, CA / ACCESSWIRE / October 31, 2024 / 180 Life Sciences Corp.   today announced the retention of Mr. Vaclav Vincalek as Senior Technology Consultant. An accomplished technologist with a strong record in technical leadership and strategy, Mr. Vincalek has guided numerous software businesses in areas of team development, technology systems architecture, and stakeholder communication.Mr. Vincalek will work closely with management to oversee the onboarding of the recently acquired Gaming Technology Platform. Commencing this integration process marks a significant step forward in the Company's efforts to establish a robust online gaming infrastructure.With the addition Mr. Vincalek's expertise in technology strategy, 180 continues to take measures to position itself as a leader in innovative solutions across diverse technology sectors. This strategic move underscores the Company's commitment to enhancing its capabilities and expanding its offerings within the rapidly evolving gami","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/180-life-sciences-corp-retains-120000071.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ATNF","BK4585","BK4139","MAA","BK4588","ATNFW","BK4215"],"gpt_icon":0},{"id":"2479044234","title":"180 Life Sciences appoints Jay Goodman to board of directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2479044234","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479044234?lang=en_us&edition=full_marsco","pubTime":"2024-10-29 20:52","pubTimestamp":1730206335,"startTime":"0","endTime":"0","summary":"180 Life Sciences (ATNF) announced the appointment of Jay Goodman to its Board of Directors, effective immediately. Currently, Goodman serves as Sa...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/180-life-sciences-appoints-jay-goodman-to-board-of-directors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/180-life-sciences-appoints-jay-goodman-to-board-of-directors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ATNF"],"gpt_icon":0},{"id":"2479409478","title":"180 Life Sciences Corp. Appoints Mr. Jay Goodman to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2479409478","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479409478?lang=en_us&edition=full_marsco","pubTime":"2024-10-29 20:00","pubTimestamp":1730203200,"startTime":"0","endTime":"0","summary":"PALO ALTO, CA / ACCESSWIRE / October 29, 2024 / 180 Life Sciences Corp.   today announced the appointment of Mr. Jay Goodman to its Board of Directors, effective immediately. Mr. Goodman brings over a decade of expertise in the software-as-a-service  and iGaming industries, along with more than seven years of experience in executive leadership roles. Mr. Goodman's distinguished career includes contributions to several high-growth companies, successful IPOs, and extensive work in the Asia Pacific and Japan markets.\"We are thrilled to welcome Mr. Goodman to our Board,\" said Blair Jordan, Interim CEO of 180. \"His depth of experience in SaaS, coupled with his extensive background in iGaming and leadership, will be instrumental to our company's evolving strategy. As we expand into the online gaming market, his proven track record in guiding companies through rapid growth and market transitions will be invaluable.\"","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/180-life-sciences-corp-appoints-120000354.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MAA","BK4588","BK4215","BK4139","BK4585","ATNF","ATNFW"],"gpt_icon":0},{"id":"2478093318","title":"BRIEF-Elray Resources Announces Strategic Sale Of Crypto Igaming Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2478093318","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478093318?lang=en_us&edition=full_marsco","pubTime":"2024-10-25 21:44","pubTimestamp":1729863892,"startTime":"0","endTime":"0","summary":"Oct 25 (Reuters) -    * ELRAY RESOURCES ANNOUNCES STRATEGIC SALE OF CRYPTO IGAMING TECHNOLOGYSource text for Eikon:    ((Reuters.Briefs@thomsonreuters.com))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATNF"],"gpt_icon":0},{"id":"2478987859","title":"Elray Resources Announces Strategic Sale of Crypto Igaming Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2478987859","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478987859?lang=en_us&edition=full_marsco","pubTime":"2024-10-25 21:00","pubTimestamp":1729861200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241025:nTUA4R4W3C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4150","ATNF","ELRA"],"gpt_icon":0},{"id":"2476720131","title":"180 Life Sciences' Brave Decision To Switch to the iGaming Industry","url":"https://stock-news.laohu8.com/highlight/detail?id=2476720131","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2476720131?lang=en_us&edition=full_marsco","pubTime":"2024-10-17 22:52","pubTimestamp":1729176757,"startTime":"0","endTime":"0","summary":"October 17, 2024 180 Life Sciences Corporation , which first focuses on a biotechnology business, decided to switch to the online gambling and gaming business on Oct. 16, 2024, Wednesday.This pivoting move has brought volatility to the company's stock price. At the closing market, ATNF recorded a 325.66% uptick in price.180 Life Sciences is now officially open for online gambling and gaming business after obtaining a fully integrated back-end technology infrastructure to host online casinos. With this acquisition, the company expects to get a substantial market share in the exciting iGaming industry that is expected to reach $133 billion by 2029.GuruFocus has detected 1 Warning Sign with ATNF.The change of direction is unanticipated since the company has been concentrating on the biotechnology field, the shift may bring fresh growth prospects and help to diversify the company's revenue sources which is not profitable so far.Don't just read the latest news - make informed investment dec","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/ROIbaCwW0ZXUgQB6WgcRtQ--~B/aD0xODA7dz0xODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/21c2dcc65b44da7483180fa2976017c3","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/ROIbaCwW0ZXUgQB6WgcRtQ--~B/aD0xODA7dz0xODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/21c2dcc65b44da7483180fa2976017c3"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/180-life-sciences-brave-decision-145237997.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4513","SWCH","ATNFW","BK4139","LU1093756325.SGD","LU1093756168.USD","ATNF","BK4116"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.180lifesciences.com","stockEarnings":[{"period":"1week","weight":0.0722},{"period":"1month","weight":-0.2037},{"period":"3month","weight":-0.4538},{"period":"6month","weight":-0.8683},{"period":"1year","weight":-0.6056},{"period":"ytd","weight":-0.5319}],"compareEarnings":[{"period":"1week","weight":0.0689},{"period":"1month","weight":-0.0421},{"period":"3month","weight":-0.074},{"period":"6month","weight":-0.0742},{"period":"1year","weight":0.0553},{"period":"ytd","weight":-0.0801}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. The company product development platforms includes fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed Phase IIb clinical trials that focuses on fibrosis and anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are synthetic pharmaceutical grade molecules close or distant analogs of non-psychoactive cannabinoids, such as CBD for the treatment of inflammatory diseases and pain; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. 180 Life Sciences Corp. is headquartered in Palo Alto, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.032089},{"month":2,"riseRate":0.5,"avgChangeRate":-0.000209},{"month":3,"riseRate":0.25,"avgChangeRate":-0.079985},{"month":4,"riseRate":0.375,"avgChangeRate":-0.025404},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.083472},{"month":6,"riseRate":0.857143,"avgChangeRate":-0.034568},{"month":7,"riseRate":0.625,"avgChangeRate":0.016254},{"month":8,"riseRate":0,"avgChangeRate":-0.1102},{"month":9,"riseRate":0.5,"avgChangeRate":-0.055536},{"month":10,"riseRate":0.25,"avgChangeRate":0.086691},{"month":11,"riseRate":0.25,"avgChangeRate":-0.175583},{"month":12,"riseRate":0.375,"avgChangeRate":-0.169849}],"exchange":"NASDAQ","name":"180 Life Sciences Corp","nameEN":"180 Life Sciences Corp"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.33.1","shortVersion":"4.33.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"180 Life Sciences Corp(ATNF),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest 180 Life Sciences Corp(ATNF) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"180 Life Sciences Corp,ATNF,180 Life Sciences Corp股票,180 Life Sciences Corp股票老虎,180 Life Sciences Corp股票老虎国际,180 Life Sciences Corp行情,180 Life Sciences Corp股票行情,180 Life Sciences Corp股价,180 Life Sciences Corp股市,180 Life Sciences Corp股票价格,180 Life Sciences Corp股票交易,180 Life Sciences Corp股票购买,180 Life Sciences Corp股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"180 Life Sciences Corp(ATNF),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest 180 Life Sciences Corp(ATNF) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}